| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/15/2000 | WO2000034446A1 Inactivation of non-enveloped viruses |
| 06/15/2000 | WO2000034444A2 Method and composition for preserving viruses |
| 06/15/2000 | WO2000034443A2 Megakaryocyte-induced expansion of hematopoietic stem cells |
| 06/15/2000 | WO2000034442A2 Application of shear flow stress to smooth muscle cells for the production of implantable structures |
| 06/15/2000 | WO2000033879A1 Method for the treatment of inflammation |
| 06/15/2000 | WO2000033875A1 Chemotherapeutic composition and method |
| 06/15/2000 | WO2000033870A2 New cancer treatments |
| 06/15/2000 | WO2000033869A2 Use of human prostrate cell lines in cancer treatment |
| 06/15/2000 | WO2000033865A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | WO2000033863A2 Therapeutic agent for the suppression of snoring noises |
| 06/15/2000 | WO2000033854A1 Preparation that contains oligosaccharides and probiotics |
| 06/15/2000 | WO2000033853A1 Anti-coagulation with calcium containing citrate solution |
| 06/15/2000 | WO2000015649A9 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 06/15/2000 | WO2000010600A3 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents |
| 06/15/2000 | WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/15/2000 | WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 06/15/2000 | WO2000008192A3 Herpesviral vectors for gene delivery |
| 06/15/2000 | WO2000006701A9 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 06/15/2000 | WO1999061052A9 Oral immunization with papillomavirus virus-like particles |
| 06/15/2000 | WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 06/15/2000 | DE19856897A1 Therapeutikum zur Unterdrückung von Schnarchgeräuschen A therapeutic agent for suppressing snoring noises |
| 06/15/2000 | DE19856065A1 Rekombinanter, adenoviraler Vektor mit limitierter Autoreplikationsfähigkeit in vivo A recombinant adenoviral vector with limited car capacity for replication in vivo |
| 06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2354189A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | CA2354188A1 Cancer cell vaccine |
| 06/15/2000 | CA2353620A1 Methods and formulations for reducing circulating antibodies |
| 06/15/2000 | CA2353578A1 Application of shear flow stress to smooth muscle cells for the production of implantable structures |
| 06/15/2000 | CA2353522A1 Treatment of pompe's disease |
| 06/15/2000 | CA2353469A1 Therapeutic agent for the suppression of snoring noises |
| 06/15/2000 | CA2351890A1 Method and composition for preserving viruses |
| 06/15/2000 | CA2351628A1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 06/15/2000 | CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3 |
| 06/14/2000 | EP1008653A2 Recombinant adenoviral vector with limited capability to self-replicate |
| 06/14/2000 | EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 06/14/2000 | EP1008604A1 Cell chemotactic factor (cctf) originating in mammalian tooth precement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient |
| 06/14/2000 | EP1008024A2 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 06/14/2000 | EP1007965A4 Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| 06/14/2000 | EP1007965A1 Use of anti-embryonic hemoglobin antibodies to identify fetal cells |
| 06/14/2000 | EP1007720A1 Dendritic cell hybrids |
| 06/14/2000 | EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 06/14/2000 | EP1007686A1 Tuberculosis vaccine |
| 06/14/2000 | EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 06/14/2000 | EP1007662A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
| 06/14/2000 | EP1007645A1 Human serum inducible kinase (snk) |
| 06/14/2000 | EP1007640A1 New spumavirus isolated from humans |
| 06/14/2000 | EP1007639A1 GLUCOSE RESPONSIVE $g(b)-CELL LINE |
| 06/14/2000 | EP1007636A2 Cultures of human cns neural stem cells |
| 06/14/2000 | EP1007634A1 Encapsulation of living tissue cells in a microsphere |
| 06/14/2000 | EP1007632A1 Isolation of bone and cartilage precursor cells |
| 06/14/2000 | EP1007631A1 Cardiac muscle regeneration using mesenchymal stem cells |
| 06/14/2000 | EP1007630A1 Natural killer cell lines and methods of use |
| 06/14/2000 | EP1007625A1 Immunity enhancing lactic acid bacteria |
| 06/14/2000 | EP1007561A2 Novel conjugates of opioids and endogenous carriers |
| 06/14/2000 | EP1007559A1 Genetically engineered cells which express bone morphogenetic proteins |
| 06/14/2000 | EP1007543A1 A method for stimulating red blood cell production |
| 06/14/2000 | EP1007183A1 Blood processing chamber counter-balanced with blood-free liquid |
| 06/14/2000 | EP1007087A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION |
| 06/14/2000 | EP1007068A1 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 06/14/2000 | EP1007064A1 Regeneration of nerves in the central nervous system |
| 06/14/2000 | EP1007063A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
| 06/14/2000 | EP1007061A1 Process for the preparation of platelet growth factors extract for wound healing compositions |
| 06/14/2000 | EP1007060A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
| 06/14/2000 | EP1006817A1 A food supplement composition based on dehydrated crab meat |
| 06/14/2000 | EP1006801A1 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
| 06/14/2000 | EP0667785B1 Method of treating non-streptococcal bacterial infections |
| 06/14/2000 | CN1256635A Peptide-coated implants and methods for producing same |
| 06/14/2000 | CN1256145A Chinese medicine composition for treating toothache |
| 06/14/2000 | CN1256135A Tuberculosis treating medicine and its compounding process |
| 06/14/2000 | CN1256132A Medicine for enuresis and its preparation |
| 06/14/2000 | CN1256130A Scald-treating fumigation roll |
| 06/14/2000 | CN1053466C Process of making scorpion soaking wine |
| 06/14/2000 | CN1053377C Viscosity-reducing Chinese medicine capsule for treatment of high blood viscosity disease |
| 06/14/2000 | CN1053376C Antineoplastic Chinese medicine prepn. and its preparing process |
| 06/14/2000 | CN1053373C Ointment for treatment of psoriasis and prep. thereof |
| 06/14/2000 | CN1053370C Method for prepn. of Jiyidan pill |
| 06/14/2000 | CN1053368C Pill for treatment of nephritis |
| 06/14/2000 | CN1053367C Health wine and its prep. process |
| 06/14/2000 | CN1053365C Nutrient for youngsters |
| 06/14/2000 | CN1053364C Natural traditional Chinese medicine face-beautifying extract |
| 06/14/2000 | CN1053362C Baicaoshengshou oral liquid and its prep. |
| 06/14/2000 | CN1053356C Kidney-tonifying and life-prolonging wine |
| 06/14/2000 | CN1053355C Medicated wine composition for curing sciatica |
| 06/14/2000 | CN1053352C Health medicinal liquor |
| 06/14/2000 | CN1053348C Medicine for curing scald and burn |
| 06/14/2000 | CN1053347C Chinese pill for treatment of hepatic disease |
| 06/14/2000 | CN1053345C Adipsa soft extract and its prep. |
| 06/14/2000 | CN1053344C Chinese drug pill for treatment of cold |
| 06/14/2000 | CN1053343C Chinese tablet for treatment of tuberculosis of lung |
| 06/14/2000 | CN1053342C Prepn. process of thrombus dissolving agent for snake venom |
| 06/13/2000 | US6075017 Compositions for the treatment of dandruff |
| 06/13/2000 | US6074875 Materials and methods relating to the regulation of polypeptide production in cells |
| 06/13/2000 | US6074869 Preparing a melt-blown nonwoven web; comprising surface adjusting a melt-blown non-woven web characterized by timed fluid flow in different directions |
| 06/13/2000 | US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein |
| 06/13/2000 | US6074846 Hepatitis C virus asialoglycoproteins |
| 06/13/2000 | US6074637 Modifying cells by transfection with dna |
| 06/13/2000 | US6074635 T cell activation |